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Introduction {#sec1}
============

(Hetero)aryl halides (Br, Cl, I) are embodied in many biologically important molecules, like natural products, drugs, and drug leads ([@bib20]). In organic molecules, replacing a proton by a halide can significantly improve their properties, including solubility, polarity, melting point, stability, binding affinity, selectivity to biological targets, and metabolism. Recently, halogen bonding emerges as a useful tool in both catalyst and drug design ([@bib48]). For example, chloride is normally used as bioisostere of methyl and hydroxyl groups, whereas bromide is frequently used as bioisostere of isopropyl and trifluoromethyl groups. The isotopes of iodide, like ^123^I and ^131^I, are widely used in medical setting for imaging, such as iopanoic acid. Meanwhile, as one of the most useful building blocks in organic synthesis, (hetero)aryl halides are broadly utilized in countless transformations like cross-couplings (e.g., Suzuki coupling, Buchwald-Hartwig coupling, Ullman coupling) ([@bib22]) ([Figure 1](#fig1){ref-type="fig"}A).Figure 1Previous Approach for Halogenation (Br, Cl, I) and Our Strategy(A) Typical examples of biologically important (hetero)aryl halides.(B--D) (B) Previous reported approaches for halogenation developed in laboratories. (C) The reaction mechanism of vanadium haloperoxidases (V-HPO) and comparison of V-η^2^-peroxy and W-η^2^-peroxy intermediates. (D) Biomimetic halogenation catalyzed by tungstate. HMPT, hexamethylphos-phor triamide.

Conventional approach to introduce halides (Br, Cl, I) on (hetero)arenes heavily relies on electrophilic halogenation with various of reagents, like chlorine, bromine, iodine, NCS, NBS, ^*t*^BuOCl, and Palau\'chlor^4^ ([@bib35]). Such electrophilic halogenation process, unavoidably, generates another part of molecule as waste, like HBr and succinimide from bromine and NBS, respectively. Besides, they also suffer from being erosive, explosive, or toxic. The Sandmeyer reaction ([@bib27]) is another commonly used approach to prepare (hetero)aryl halides. However, multiple steps, lots of chemical wastes, and harsh reaction conditions are necessary. Oxidative halogenation serves as an important alternative ([@bib33]), like transition metal (TM)-catalyzed C-H bond functionalization ([@bib32]), photo-/electrocatalysis (Br, Cl) ([@bib19]; [@bib50], [@bib29]), and HX (X = Br, Cl)/oxidant ([@bib15], [@bib42], [@bib37], [@bib8]). Albeit significant progress has been achieved, there is still large room to improve. For example, the TM-catalyzed oxidative halogenations normally require noble catalysts, directing groups, harsh conditions, or costly oxidants. Some frequently encountered functional groups cannot be tolerated in electrocatalysis, such as alkyl carboxylic acids (Kolbe electrolysis). Acid-sensitive groups (e.g., alkene, *tert*-butylcarbamate, alcohol, and basic *N*-atoms) and primary/secondary alcohols ([@bib42]) cannot survive well in HX/oxidant as well. The large-scale synthesis (\>100g) is also quite challenging for these methods, due to cost-unfriendly reagents, harsh conditions, or difficulties in purification. Halogenation in nature, on the other hand, can be achieved in high selectivity even with complex molecules under mild conditions via utilizing nucleophilic halides by enzymes, like metalloenzymes and flavoenzymes ([@bib28], [@bib9], [@bib17], [@bib45]). However, its industrial application still needs improvements in several aspects due to limited substrate scopes, high requirements of condition to maintain enzyme activity (solvent, temperature, pH, and so on), and inconvenient isolation process in large-scale synthesis ([Figure 1](#fig1){ref-type="fig"}B).

The biomimetic halogenation provides a possible access to such ideal halogenation. Inspired by vanadium haloperoxidases (V-HPO) ([@bib28], [@bib49]), vanadium-catalyzed biomimetic halogenation ([@bib36]) has attracted lots of attention. According to the mechanism, a V-η^2^-peroxy intermediate (**V-II**) was formed first in the presence of H~2~O~2~ and then opened by halide assisted by H-bonding from proximate lysine, yielding an electrophilic hypohalite (OX^−^, HOX or V-OX, X = Br, Cl, I) captured by (hetero)arenes ([@bib49]) ([Figure 1](#fig1){ref-type="fig"}C, I). However, vanadium is difficult for industrial production as critical hazard by Europea Union regulation ([@bib3]). Theoretically, any transition metal can also fulfill such biomimetic halogenations if only they can form such η^2^-peroxy intermediates. Thus, many researches have focused on searching for other TM catalysts for this biomimetic halogenation ([@bib18]). However, low pH condition was normally required to maintain the activity of catalysts, and many acid-sensitive functional groups cannot be tolerated. Actually, development of biomimetic halogenation under mild pH is a long-time challenge. Among them, tungsten (W) ([@bib7], [@bib40], [@bib4]) has attracted great interest. Given that W-η^2^-peroxy intermediate has more charged metal ion-bearing larger-radii (W^6+^, 60 pm versus V^5+^ 46 pm) and longer O-O bonds than those of V-η^2^-peroxy intermediate (151, 153 pm for W, 143--146 nm for V) ([@bib34], [@bib1], [@bib31], [@bib13], [@bib43], [@bib12], [@bib6]), it is supposed to be a better peroxy electrophile as observed in oxidation of (thiolato)-cobalt (III) complexes ([@bib16]). Meanwhile, the electrophilicity of W-η^2^-peroxy, we believe, can be further enhanced by Brønsted or Lewis acid ([@bib26]), promoting the formation of hypohalous species (**W-III**, HOX) ([@bib38]). From this perspective, biomimetic W-catalyzed halogenation under mild pH could be possible ([Figure 1](#fig1){ref-type="fig"}C, II). Herein, we present such a tungstate-catalyzed, biomimetic oxidative halogenation (Br, Cl, I) of (hetero)arene in a scalable (\>100 g), inexpensive, environment- and operation-friendly manner, along with broad substrate scope, diverse functional group tolerance, and good chemo- and regioselectivity ([Figure 1](#fig1){ref-type="fig"}D).

Results and Discussion {#sec2}
======================

Condition Optimization for Tungstate-Catalyzed Oxidative Bromination of (Hetero)Arene {#sec2.1}
-------------------------------------------------------------------------------------

Initially, aniline **1-1** was selected as model substrate for our hypothesis. After lots of efforts in condition screening, ultimately the desired product **2-1** can be obtained in good yield in the presence of 5 mol % sodium tungstate, 1.1 equivalents of NaBr, and 6.0 equivalents of H~2~O~2~ (30% aq.) in EtOH assisted by adding 1.1 equivalents of HOAc ([Table 1](#tbl1){ref-type="table"}, entry 1). The reaction still moved on but at a much slower rate without adding HOAc ([Table 1](#tbl1){ref-type="table"}, entry 2). Only trace amount of the product can be detected by thin-layer chromatography without catalyst in background reaction ([Table 1](#tbl1){ref-type="table"}, entry 3). Polyoxotungstate also worked well in this reaction, with a little bit lower yield ([Table 1](#tbl1){ref-type="table"}, entry 4 and 5). Other bromides, like LiBr and KBr, afforded the product **2-1** as well in eroded efficiency ([Table 1](#tbl1){ref-type="table"}, entry 6 and 7). Sodium perborate failed to afford any product ([Table 1](#tbl1){ref-type="table"}, entry 8). Other protonic solvents, like MeOH, also worked smoothly ([Table 1](#tbl1){ref-type="table"}, entry 9). Notably, the reaction went on well even in H~2~O, although both starting material and product were not well dissolved ([Table 1](#tbl1){ref-type="table"}, entry 10). Decreasing the loading of either catalyst or H~2~O~2~ evidently reduced the reaction efficiency ([Table 1](#tbl1){ref-type="table"}, entry 11-12). Only trace *ortho*-bromination (**2-1B**), dibromination (**2-1C**), and nitroso products (**2-1D**) were observed in all condition screenings. In addition, no azo or azoxy products were observed ([@bib25]), demonstrating good chemo- and regioselectivity of this transformation ([Tables 1](#tbl1){ref-type="table"}, see also [S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"} and [Figure S6](#mmc1){ref-type="supplementary-material"}).Table 1Condition Optimization![](fx2.gif)EntryVary from Optimized ConditionYield[a](#tblfn1){ref-type="table-fn"}Major By-products1None78%--83%![](fx3.gif)2Without HOAc\<50% conversion for 3 days3Without Na~2~WO~4~-2H~2~OTrace[b](#tblfn2){ref-type="table-fn"}4H~3~O~40~PW~12~-xH~2~O instead of Na~2~WO~4~-2H~2~O64%[c](#tblfn3){ref-type="table-fn"}5(NH~4~)~10~(H~2~W~12~O~42~)-xH~2~O instead of Na~2~WO~4~-2H~2~O77%[c](#tblfn3){ref-type="table-fn"}![](fx4.gif)6LiBr instead of NaBr66%[d](#tblfn4){ref-type="table-fn"}7KBr instead of NaBr75%[d](#tblfn4){ref-type="table-fn"}8SPB instead of H~2~O~2~N.R9MeOH instead of EtOH67%![](fx5.gif)10H~2~O instead of EtOH67%11Na~2~WO~4~-2H~2~O, 1 mol % instead of 5 mol %67%122.0 equiv H~2~O~2~ instead of 6.0 equiv57%[^2][^3][^4][^5][^6]

Substrate Scope of Tungstate-Catalyzed Oxidative Bromination {#sec2.2}
------------------------------------------------------------

With the optimized reaction condition at hand, the substrate scope for bromination was investigated as summarized in [Table 2](#tbl2){ref-type="table"}. Overall, anilines, phenols, other electronically rich (hetero)arenes, and carbonyl compounds can all afford the bromination products smoothly in moderate to excellent yield. Diverse functional groups were well tolerated, including ester (**2-1**, **2-3**, **2-11**, **2-16**, **2-20**), amide (**2-2**, **2-12**), hydroxy (**2-7** to **2-12**), nitrone (**2-4**, **2-10**), halogens (**2-7**, **2-22**), morpholine (**2-6**), methoxy (**2-13**, **2-14**), carboxylic acid (**2-9**), and ketone (**2-15**). Good to excellent chemo- and regioselectivity were observed as well. The *para*-product was favored over *ortho*-product (e.g., **2-1**, **2-2,** and **2-6**). The unprotected amine groups in anilines remained untouched, even though the azoxy formation could dominate the reaction ([@bib25]). Unlike the dimerization and dearomatization frequently encountered under similar conditions ([@bib11]), the oxidative bromination of phenol still worked smoothly in this reaction. Adding 2.2 equiv NaBr and HOAc, the dibromination products can be easily prepared as well (**2-10**, **2-11**, **2-12**) ([Figure 2](#fig2){ref-type="fig"}B). Interestingly, only monobromination of 1,3,5-trimethoxy benzene (**2-14**) was observed without any dibromination product and 1,3-dicarbonyl compounds afforded the α-bromination product.Table 2Substrate Scope of Tungstate-Catalyzed Oxidative Bromination of (Hetero)Arene![](fx6.gif)![](fx7.gif)![](fx8.gif)![](fx9.gif)![](fx10.gif)![](fx11.gif)**2-1**, 91% (*p: o: d* = 21:1:1)**2-2**, 52%**2-3**, 85% (89%[a](#tblfn5){ref-type="table-fn"} in H~2~O)**2-4**, 75% (90% brsm)**2-5**, 69%[b](#tblfn6){ref-type="table-fn"}![](fx12.gif)![](fx13.gif)![](fx14.gif)![](fx15.gif)![](fx16.gif)**2-6**, 57%**2-7**, 65% (76%[a](#tblfn5){ref-type="table-fn"} in H~2~O)**2-8**, 54%**2-9**, 70%**2-10**, 93%[c](#tblfn7){ref-type="table-fn"}![](fx17.gif)![](fx18.gif)![](fx19.gif)![](fx20.gif)![](fx21.gif)**2-11**, 86%[c](#tblfn7){ref-type="table-fn"}**2-12**, 83%[c](#tblfn7){ref-type="table-fn"}**2-13**, 86%**2-14**, 98% (92%[a](#tblfn5){ref-type="table-fn"} in H~2~O)**2-15**, 62% yield![](fx22.gif)![](fx23.gif)![](fx24.gif)![](fx25.gif)![](fx26.gif)**2-16**, 81%**2-17**, 74%**2-18**, 73%**2-19**, 72%**2-20**\
52% (*m*: *d* = 5:1)![](fx27.gif)![](fx28.gif)![](fx29.gif)![](fx30.gif)![](fx31.gif)**2-21**, 38% (79% brsm)**2-22**, 92%**2-23**, 79%**2-24**, 61% (*m: d* = 2:1)**2-25**, 33%![](fx32.gif)![](fx33.gif)![](fx34.gif)![](fx35.gif)**2-26**, 97% (tolfenamic acid)**2-27**, 74% (sulfapyridine)**2-28**, 34% (98% brsm)\
(derived from tyrosine)**2-29**, 31% (45% brsm)\
(indole-2-one)![](fx36.gif)![](fx37.gif)![](fx38.gif)**2-30**, 48% (56% brsm, m: d = 11:1)\
(estrone)**2-31**, 83% (by HNMR)\
(cytidine)**2-32**, 75% (by NMR, 2:1 rr)\
(naringin)[^7][^8][^9][^10][^11]Figure 2Application in Synthesis of Selected Drugs and Key Precursors(A) Synthesis of quinoline drugs or key precursors, including clioquinol, iodoquinado, broxyquinoline, and precursor for broxaldine.(B) Synthesis of key precursor for brimonidine, a drug to treat ocular hypertension, rosacea, and open-angle glaucoma.(C) Synthesis of key precursor bromopride and metoclopramide, antiemetic drugs.(D) Synthesis for benzofuran drugs: benzbromaron, benziodarone, and amiodarone.

As it is well known, the Lewis basicity of nitrogen (N) could hamper the reaction by coordinating to transition metals as observed in halogenation catalyzed by Pd, Cu, Rh, and Ru ([@bib32], [@bib46]). In addition, heteroarenes bearing strong basic nitrogen (e.g., pyridine, isoquinoline, and quinolone) can form salts with HOAc, leading to a decrease in their nucleophilicity and enhancement of the pH value in the reaction. Surprisingly, the bromination of *N*-containing heteroarenes still proceeded smoothly in our reaction, including indole (**2-16**), indole analogs (**2-17**, **2-18**, **2-19**), pyrroles (**2-20**, see also [Figure S7](#mmc1){ref-type="supplementary-material"}), carbazone (**2-21**), imidazo\[1,2-a\]pyridine (**2-22**), pyridine (**2-23**), isoquinoline (**2-24**, see also [Figure S8](#mmc1){ref-type="supplementary-material"}), and quinoline (**2-25**). Actually, the reactions were conducted in neutral condition to some extent for those basic heteroarenes. Of note, no *N*-oxide products were observed in all tested heteroarenes, indicating excellent chemoselectivity in this reaction.

Late-stage bromination of complex molecules, like drug leads and bioactive natural products, is highly appealing, facilitating quick structure-activity relationship studies given the diverse transformations based on aryl bromides. It is reasonable to hypothesize that the selective late-stage bromination of complex molecules can be achieved, considering the good functional group tolerance as observed in previous studies. However, it can be challenging to obtain good chemo- and regioselectivities for substrates bearing multiple reaction sites with slightly different chemical surroundings. Nonetheless, the late-stage bromination of complex molecules was proved to be successful in our reaction. For instance, the slight difference of multiple reactive positions in olfenamic acid (**2-26**) and sulfapyridine (**2-27**) could be distinguished, affording the single monobromination products in high yield. Tyrosine (**2-28**), indole-2-one (**2-29**), and estrone (**2-30**, see also [Figure S9](#mmc1){ref-type="supplementary-material"}) also yielded the monobromination products in good chemo- and regioselectivity. It is worth pointing out that the acid-sensitive *tert*-butylcarbamate group was well tolerated in our reaction, demonstrating that our approach has better functional group tolerance than that of reported HX/oxidant system. Notably, saccharide scaffolds are maintained untouched, as shown in cytidine (**2-31**, see also [Figure S10](#mmc1){ref-type="supplementary-material"}) and naringin (**2--32**, see also [Figure S11](#mmc1){ref-type="supplementary-material"}), albeit many oxidant transformations could occur with such multiple unprotected hydroxyl groups. Water is the ideal reaction solvent, from the perspective of cost and environmental concerns. Delightfully, our reaction worked in water as well (see also [Table S3](#mmc1){ref-type="supplementary-material"}), giving comparable results as those in EtOH (**2-2**, **2-3**, **2-7**, **2-14**).

Substrate Scope of Tungstate-Catalyzed Oxidative Chlorination and Iodination {#sec2.3}
----------------------------------------------------------------------------

The oxidative chlorination and iodination were also investigated as summarized in [Table 3](#tbl3){ref-type="table"}. Noticing that the redox potential of chloride is higher than that of bromide, oxidative chlorination was more challenging. Indeed, unlike the fact that the bromination worked smoothly with NaBr and KBr, no chlorination product was observed in the presence of NaCl or KCl. After tedious efforts in condition optimization, ultimately it was found that BaCl~2~ could afford the chlorination products in best yield with model substrate **1-1** (see also [Tables S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}). Aniline, phenol, other electronically rich (hetero)arenes, and carbonyl compounds all worked well. Good functional group tolerance was observed as well, including ester (**2-33**, see also [Figure S12](#mmc1){ref-type="supplementary-material"}; **2-40**), free aniline (**2-33**, **2-34**), morpholine (**2-35**, see also [Figure S13](#mmc1){ref-type="supplementary-material"}), halide (**2-36**, **2-42**), alkoxyl (**2-37**), carboxylic acid (**2-38**), and ketone (**2-39**). Compared with bromination, chlorination generally required longer reaction time and higher reaction temperature. Although iodide is easier to be oxidized than bromide, such biomimetic oxidative iodination of (hetero)arenes is scarcely reported ([@bib39]). Moreover, the aryl iodide product can potentially be further oxidized into hyperiodide species ([@bib5]), leading to undesired by-products. To our delight, such overoxidation was not observed in this reaction ([@bib14]). Selected substrates were investigated, and all afforded the products in moderate to excellent yield, including aniline (**2-43**, **2-45**), phenol (**2-44**), and heteroarene (**2-46**, **2-47**). It should be pointed out that the background of iodination worked as well without catalyst. However, the catalyst acceleration was also evident as observed in some substrates, and longer reaction time is required without catalyst (**2-45**, **2-47**).Table 3Substrate Scope of Tungstate-Catalyzed Oxidative Chlorination and Iodination![](fx39.gif)![](fx40.gif)![](fx41.gif)![](fx42.gif)![](fx43.gif)![](fx44.gif)**2-33**[a](#tblfn8){ref-type="table-fn"}, 81% (p: *o* = 2.2: 1)**2-34**[a](#tblfn8){ref-type="table-fn"}, 49% (64% brsm)**2-35**[a](#tblfn8){ref-type="table-fn"}, 58% (p: *o* = 1: 3.5)**2-36**[a](#tblfn8){ref-type="table-fn"}, 82%[b](#tblfn9){ref-type="table-fn"}**2-37**[a](#tblfn8){ref-type="table-fn"}, 51% (74% brsm)![](fx45.gif)![](fx46.gif)![](fx47.gif)![](fx48.gif)![](fx49.gif)**2-38**[a](#tblfn8){ref-type="table-fn"}, 44% (56% brsm)**2-39**[a](#tblfn8){ref-type="table-fn"}, 43%**2-40**[a](#tblfn8){ref-type="table-fn"}, 70% (91% brsm)**2-41**[a](#tblfn8){ref-type="table-fn"}, 56% (62% brsm)**2-42**[a](#tblfn8){ref-type="table-fn"}, 35% (78% brsm)![](fx50.gif)![](fx51.gif)![](fx52.gif)![](fx53.gif)![](fx54.gif)**2-43**[c](#tblfn10){ref-type="table-fn"}, 39% (48% brsm)**2-44**[c](#tblfn10){ref-type="table-fn"}^,^[d](#tblfn11){ref-type="table-fn"}^,^[e](#tblfn12){ref-type="table-fn"}, 97%[d](#tblfn11){ref-type="table-fn"} (13 h)\
(93%[e](#tblfn12){ref-type="table-fn"}, w/o. cat.,17 h)**2-45**[c](#tblfn10){ref-type="table-fn"}^,^[d](#tblfn11){ref-type="table-fn"}, 65%[d](#tblfn11){ref-type="table-fn"} (40 min)\
(66%e, w/o. cat., 6 h)**2-46**[c](#tblfn10){ref-type="table-fn"}, 89% (15 min)\
(96%[e](#tblfn12){ref-type="table-fn"}, w/o. cat., 15 min)**2-47**[c](#tblfn10){ref-type="table-fn"}, 97% (20 min)\
(99%[e](#tblfn12){ref-type="table-fn"}, w/o. cat., 1 h)[^12][^13][^14][^15][^16][^17]

100-g-Scale Preparation of (Hetero)Aryl Bormide {#sec2.4}
-----------------------------------------------

The reaction can be scaled up to over 100 g without any erosion of efficiency, including aniline ([Table 4](#tbl4){ref-type="table"}, **2-1** and **2-3**), phenol ([Table 4](#tbl4){ref-type="table"}, **2-11**), and other electronically rich (hetero)arene ([Table 4](#tbl4){ref-type="table"}, **2-14** and **2-23**). Of note, the reaction can be conducted in beakers in the open air, and the products precipitated upon completion during gram-scale reaction, obtained in high purity only by filtration and washing (see also [Figure S5](#mmc1){ref-type="supplementary-material"}). These results suggested the good potential of our reaction in industrial preparation of (hetero)aryl halide.Table 4100-g-Scale Bromination![](fx55.gif)![](fx56.gif)![](fx57.gif)![](fx58.gif)![](fx59.gif)![](fx60.gif)**2-1**, 93%, 221g (p: *o*: *d* = 20: 3: 3)**2-3**, 94%, 107 g**2-11**, 88%,136 g**2-14**, 99%, 123 g**2-23**, 85%, 146 g

Synthetic Application in Drugs and Key Precursors for Drugs {#sec2.5}
-----------------------------------------------------------

Many drugs and drug leads contain aryl halide (Br, Cl, I) motifs, thus we would like to explore the utility of our approach in their preparation. The quinoline halides were embodied in several antibiotic drugs and bioactive compounds, like chlorquinaldol, iodoquinadol, cloxiquine, clioquinol, and broxyquinoline. Although they were reported to be good ligands for tungsten ([@bib2]), the oxidative halogenation of 8-hydoxyquinolines was achieved successfully. Clioquinol (**2-48**), iodoquinadol (**2-49**), broxyquinoline (**2-50**), and precursor for broxaldine (**2-51**) were all obtained in moderate to good yield. Of note, all these reactions were conducted in multiple gram scale without silica gel column purification, typically like the precursor for broxalide (**2-51**) ([@bib44]) ([Figure 2](#fig2){ref-type="fig"}A). The key intermediate for brimonidine (**2-52**) ([@bib21]), a medicine to treat ocular hypertension, rosacea, and open-angle glaucoma, was conveniently prepared ([Figure 2](#fig2){ref-type="fig"}B). As dopamine antagonists are used as antiemetic drugs, both bromopride and metoclopramide bear an aryl halide motif derived from salicylic acid ([@bib24]), which were conveniently prepared from methyl 4-amino-2-methoxybenzoate according to our approach (**2-53** and **2-54**) ([Figure 2](#fig2){ref-type="fig"}C). Benzbromaron is a broadly utilized drug to treat gout. However, the dibromination of its precursor, compound **1-43**, with bromine, only afford 35% yield of benzbromarone along with the monobromination impurities ([@bib47]). By contrast, pure benzbromarone (**2-55**) was obtained in excellent yield under mild condition even without column purification by utilizing our approach. Benziodarone (**2--56**), a vasodilator, was obtained in excellent yield as well. Compared with the poor yield and chemoselectivity by utilizing NaClO/KI/NaOH ([@bib41]) the iodination of compound **1-50** worked quite well in our reaction, giving the key precursor for amiodarone (**2-57**), a drug to treat arrhythmias ([Figure 2](#fig2){ref-type="fig"}D).

Mechanism Study {#sec2.6}
---------------

To figure out whether the bromine radical is involved in this reaction, substrate **1-45** was selected as a probe. If the bromine radical existed as reaction intermediate, product **2-59** should be observed. However, only product **2-58** was isolated in moderate yield, excluding that the bromination went through radical reaction pathway ([Figures 3](#fig3){ref-type="fig"}A and see also [S14](#mmc1){ref-type="supplementary-material"}). HOAc was used only in 1.1 equivalents as reagent in this reaction, rather than solvent, to stabilize the Br^+^ species. We suppose the HOAc played dual key roles in this halogenation ([@bib30]): (1) neutralizing the hydroxyl anion from H~2~O~2~ and (2) providing H-bonding to the key W-η^2^-peroxy intermediate **W-II**. For chlorination, the chloride salts (MCl~n~) also played key dual role: (1) providing chloride and (2) being a Lewis acid to the W-η^2^-peroxy intermediate (**W-II**) similar to V-catalyzed bromination ([@bib26]). Both the HOAc and metal ion (M^n+^) can increase the electrophilicity of W-η^2^-peroxy intermediate **W-II** by H-bonding or Lewis acid-base interaction ([Figure 3](#fig3){ref-type="fig"}B). From this perspective, weakening such H-boding effect will decrease the reaction efficiency. Indeed, the reaction proceeded much slower without HOAc or in aprotic solvent, such as THF ([Figure 3](#fig3){ref-type="fig"}C, see also [Table S2](#mmc1){ref-type="supplementary-material"}). On the other side, the strength of the Lewis acidity of metal cations can control the chlorination as well, in consist with evidently different reactionefficiency when utilizing different chloride salts. For example, no chlorination product was detected in the presence of LiCl, NaCl, and KCl; however, dichlorination product **2-34C** was isolated as major product in the presence of CaCl~2~ or SrCl~2~ even reducing their loading. By contrast, monochlorination products (**2-34**, **2-34B**) were obtained as major products with BaCl~2~ even extending reaction time. In addition, the major hypohalous species in chlorination should be **W-III** rather than HOCl; otherwise, the chloride salts should not have significant impact on products\' distribution on monochlorination and dichlorination ([Figure 3](#fig3){ref-type="fig"}D, see also [Table S4](#mmc1){ref-type="supplementary-material"}).Figure 3Hypothesis of Mechanism of Bromination/Iodination and Control Experiments(A) Radical trapping experiment.(B) Hypothesis of H-bonding effect with Brønsted acid.(C) Control experiments to probe the importance of H-bonding.(D) Effects of metal ion in chloride salts in chlorination.

Proposed Reaction Mechanism {#sec2.7}
---------------------------

Other polyoxotungstate catalyst intermediates might also be involved ([@bib10]), like dinuclear peroxotungstate **W-VI** ([@bib23]), thus we used **W-IV** as a model to illustrate the reaction mechanism given that the reaction center is the peroxyl moiety. Based on all the control experiments, we proposed the reaction mechanism as following. Initially, the tungstate **W-V** would form W-η^2^-peroxy intermediate **W-V** and then **W-I** in the presence of H~2~O~2~ and HOAc. The peroxy moiety in **W-I** was opened by halide ([@bib38]) in the assistance of Brønsted acid (bromination, iodination) or Lewis acid (chlorination) to yield hypohalous species **W-III** or HOX, which was trapped by (hetero)arene via electrophilic halogenation to afford the desired products. The HOAc and EtOH can also serve as a ligand to tungstate catalyst ([Figure 4](#fig4){ref-type="fig"}).Figure 4Proposed Reaction Mechanism

In summary, we have developed a tungstate-catalyzed, biomimetic, cost-efficient, environment- and operation-friendly approach for halogenation (Br, I, Cl) of (hetero)arene under mild pH. Broad substrate scope, diverse functional group tolerance, and late-stage bromination of bioactive complex molecule were achieved in this reaction. Besides, water can be utilized as solvent and \>100-g scale reaction was conveniently accessed without column purification. Furthermore, several drugs and key precursors for drugs have been conveniently prepared. Primary mechanism studies suggested that Brønsted or Lewis acid can accelerate the reaction and control the products\' distribution.

Limitations of the Study {#sec2.8}
------------------------

Our reaction provides a green and robust access to (hetero)aryl halides and works well for most tested substrates. However, limitation still exists. For example, the chlorination normally takes longer reaction time and has lower efficiency than bromination and iodination. Some too electronically rich substrates like indole involve other undesired oxidative transformations along with halogenation. In addition, more than 1 equivalent of H~2~O~2~ is required for the completion of this reaction under current optimized conditions. Further improvement to enhance the reaction efficiency with broader substrate scope is under investigation in our laboratory.

Methods {#sec3}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Code Availability {#appsec1}
==========================

Procedure for experiments and characterization data for products are available in [Supplemental Informations](#appsec2){ref-type="fn"}. ([Figures S15--S149](#mmc1){ref-type="supplementary-material"}) Any other data are available from the corresponding author upon reasonable request.

Supplemental Information {#appsec3}
========================

Document S1. Transparent Methods, Figures S1--S149, Data S1, and Table S1
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[^1]: Lead Contact

[^2]: N.R, no reaction

[^3]: All the reactions were conducted in 1.0-mmol scale (**1-1**) for 12 h, isolated yield.

[^4]: 2.0 equivalents of HOAc was utilized.

[^5]: 1.5 equivalents NaBr and 2.0 equiv. HOAc were utilized.

[^6]: 1.5 equivalents of NaBr and 2.0 equivalents of HOAc were utilized, and the reactions were conducted at 50°C

[^7]: p, *para-*bromination product; *o, ortho*-bromination product; *m,* mono-bromination; *d,* dibromination product; rr, regioselective ration; brsm, based on recovered starting material.

[^8]: Unless noted, all the reactions were conducted in 1.0-mmol scale (**1**) with Na~2~WO~4~-2H~2~O (5 mol %), NaBr (1.1 equivalents), H~2~O~2~ (30 % aq., 6.0 equivalents.), HOAc (1.1 equiv.) in EtOH (5.0 mL) at 30°C isolated yield (see also [Figure S1](#mmc1){ref-type="supplementary-material"}).

[^9]: The reactions were conducted in H~2~O with Na~2~WO~4~-2H~2~O (2.5 mol %), NaBr (1.1 equivalent), H~2~O~2~ (30 % aq., 1.1 equivalent) and HOAc (1.1 equivalent) (see also [Figure S2](#mmc1){ref-type="supplementary-material"}).

[^10]: 5.0-mmol scale.

[^11]: 2.2 mmol NaBr (2.2 equivalents) and HOAc (2.2 equivalents) were utilized.

[^12]: brsm, based on recovered starting material; p, *para*-chlorination product; *o*, *ortho*-chlorination product.

[^13]: Unless noted, the chlorination reactions were carried out in 1.0-mmol scale (**1**) in MeCN (5.0 mL) at 50°C with Na~2~WO~4~-2H~2~O (5 mol %), H~2~O~2~ (30% aq. 4.0 equiv.), BaCl~2~·2H~2~O (1.2 equiv), and HOAc (1.0 equiv) (see also [Figure S3](#mmc1){ref-type="supplementary-material"}).

[^14]: Trifluoro acetic acid was used instead of HOAc.

[^15]: The iodination reaction was conducted in 1.0-mmol scale (**1**) in EtOH at room temperature (20--25°C) with Na~2~WO~4~-2H~2~O (5 mol %), H~2~O~2~ (30% aq. 6.0 equiv), KI (1.1 equiv), and HOAc (1.1 equiv) (see also [Figure S4](#mmc1){ref-type="supplementary-material"}).

[^16]: 2.2 equivalents of KI and HOAc were used.

[^17]: No catalyst was added as control experiments.
